Busting Myths about Psychosis & Antipsychotics with Prof Joanna Moncrieff

In this talk, Prof Joanna Moncrieff (University College London) looks at the evidence behind some common myths relating to psychosis and ‘antipsychotic’ drugs: the idea that psychosis or ‘schizophrenia’ are neurodegenerative conditions; the concept of the ‘untreated duration of psychosis’ and whether early drug treatment produces better outcomes; the famous dopamine hypothesis of schizophrenia; the

Transition from the Clinical to the Community Context

by Pino Pini, Psychiatrist in Italy and the United Kingdom, MHE board member. Reflections on occasion of two Hearing Voices events. In my professional experience I have witnessed various significant moments in the mental health sector. Below are some reflections on my relationship with the voice-hearing movement inspired by the work of Marius Romme, and

Adapting to individual differences

By Duncan Double Rach Idahu has a blog ‘Adulting with ADHD’. BBC News reports that she told BBC Podcast ‘Access All’ that she lost £200 when she late checked in for a flight, even though she did not realise she was late (see article). The article explains that Rach estimates she has lost £4000 to

Upcoming online conference by IIPDW

We are pleased to announce this second instalment of the International Institute for Psychiatric Drug Withdrawal conference series. If you are interested to join, please register at Eventbrite (click on the image above or follow this link: https://withdrawal-from-psychiatric-drugs-2.eventbrite.co.uk ). A detailed programme can be viewed (and downloaded) below:

How We Have Been Misled About Antidepressants

BY JOANNA MONCRIEFF  Our umbrella review that revealed no links between serotonin and depression has caused shock waves among the general public, but has been dismissed as old news by psychiatric opinion leaders. This disjunction begs the questions of why the public has been fed this narrative for so long, and what antidepressants are actually doing if they are not

Update on the RADAR study

By Joanna Moncrieff. Long-term antipsychotic treatment remains the standard recommended treatment for people who have psychotic episodes or a diagnosis of schizophrenia. People who have had just one episode may be supported to try and discontinue treatment, but most people with recurrent episodes are recommended to stay on antipsychotic medication for the rest of their